Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-011570
Filing Date
2025-04-30
Accepted
2025-04-30 16:09:38
Documents
1
Period of Report
2025-03-27

Document Format Files

Seq Description Document Type Size
1 form4-04302025_080434.html 4  
1 form4-04302025_080434.xml 4 11126
  Complete submission text file 0001415889-25-011570.txt   12554
Mailing Address 399 BOYLSTON STREET SUITE 1100 BOSTON MA 02116
Business Address
EVNIN LUKE (Reporting) CIK: 0001134657 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40366 | Film No.: 25895102

Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Issuer) CIK: 0001785530 (see all company filings)

EIN.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)